Cell line · CVCL_4633
501-mel
Cancer cell line, Homo sapiens. Melanoma. 37 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. 501-mel. Cell lines, record CVCL_4633. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_4633
On this page
Cell line
As Cellosaurus gives it.
- Name
- 501-mel
- Accession
- CVCL_4633
- RRID
- RRID:CVCL_4633
- Synonyms
- 501-MEL, 501 mel, 501 Mel, 501Mel, 501mel, 501MEL, 501, Mel 501, Mel501, MEL501, Me 501, Me-501, Me501
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Melanoma (NCIt C3224)
- Derived from
- Not specified (metastatic)
- Secondary accessions
- CVCL_C608
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers37
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes. | Immunity | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma. | Cell Death Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Microbial Chemical Diversity and Cytotoxic Potential From Brazilian Ferruginous Caves: A Pioneering Metabolomic Survey. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The novel amino-artemisinin derivative WHN-11 disrupts mitochondria and protein homeostasis, and induces autophagy and apoptosis in cancer cells. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Rotenoids from the Roots of Vicia faba L. (Fabaceae): Structural Characterization, Cytotoxic Effects, and Molecular Docking. | Chem Biodivers | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. | Genes Dev | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activity. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 37
See all 37 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| From the same person | 501-EBV | CVCL_A1DM |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_4633
GET https://conductscience.org/api/cell-lines/v1/CVCL_4633/papers?page=2